Skip to main content
Blake Babcock, MD, General Surgery, Loma Linda, CA, HCA Florida Mercy Hospital

BlakeDewayneBabcockMD

General Surgery Loma Linda, CA

Surgical Oncology (Other than Breast)

Complex General Surgical Oncology Fellow Loma Linda University Cancer Center

Dr. Babcock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Babcock's full profile

Already have an account?

Summary

  • I am a board certified general surgeon currently in my last year of complex general surgical oncology fellowship.

Education & Training

  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalResidency, Surgery, 2010 - 2015
  • LSU School of Medicine in Shreveport
    LSU School of Medicine in ShreveportClass of 2010
  • Louisiana State University
    Louisiana State UniversityB.S., Chemistry and Biology, 2000 - 2004

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2021 - 2025
  • FL State Medical License
    FL State Medical License 2019 - 2023
  • CA State Medical License
    CA State Medical License 2016 - 2020
  • PA State Medical License
    PA State Medical License 2010 - 2017
  • American Board of Surgery Surgery
  • American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • Dmitry Nikitin Award for Resident of the Year, Department of Surgery Drexel University College of Medicine, 2016
  • Golden Scalpel Award for Excellence in Teaching Drexel University College of Medicine, 2016
  • Joel C. Roselyn Resident Researcher of the Year Award, Department of Surgery Drexel University College of Medicine, 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Emerging Role of MDM2 as Target for Anti-Cancer Therapy: A Review  
    Shaikh MF, Morano WF, Lee J, Gleeson E,�Babcock BD, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB, Ann Clin Lab Sci, 1/1/2016

Books/Book Chapters

Lectures

  • High-risk Stage II Colon Cancer: Not All Risks Are Created Equal 
    Chicago, IL - 1/23/2018
  • Disparities in Access to Immunotherapy and Outcomes in Metastatic Cutaneous Melanoma 
    Indian Wells, CA - 1/12/2018
  • Factors Predictive of Outcomes after Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colon and Appendiceal Carcinomatosis � Single Institution Experi... 
    Indian Wells, CA - 1/11/2018
  • Join now to see all

Professional Memberships

Hospital Affiliations